In 2008, Korkaya et al. demonstrated, for the first time, that HER2 overexpression drives mammary tumorigenesis as well as tumor growth and invasion, through its effects on normal and malignant mammary stem cells. This evidence concerns the gene ERBB2 and neoplasm.